Equity Investment	9 Months Ended
Sep. 30, 2014
Equity Investment	16. On March 25, 2013, the Company made a $3,687 equity investment in TyraTech Inc. (“TyraTech”), a Delaware corporation that specializes in developing, marketing and selling pesticide products containing essential oils and other natural ingredients, to acquire an ownership position of approximately 29.27%. In February 2014, TyraTech issued 37,391,763 shares, raising approximately £1.87 ($3.1) million and issued 50,000,000 shares in July 2014 raising approximately £3.5 ($5.9) million. Due to the share issuance in both periods, the Company recognized a $954 gain from the dilution of the Company’s ownership position. Following the issuances of these new shares, as of September 30, 2014, the Company’s ownership position in TyraTech was approximately 19.28%. The Company utilizes the equity method of accounting with respect to this investment. As a result, our net income includes losses from equity method investments which represents our proportionate share of TyraTech’s estimated net losses for the current accounting period. For the nine months ended September 30, 2014, the Company recognized an operating loss of $633 ($237 for the three months ended September 30, 2014) as a result of the Company’s ownership position in TyraTech. The Company’s investment in TyraTech is included in other assets on the condensed consolidated balance sheets. At September 30, 2014, the carrying value of the Company’s investment in TyraTech was $3,022, and the quoted market value of its shareholding was $6,321 based on the London Stock Exchange, Alternative Investment Market (“AIM”).

Equity Investment

9 Months Ended

Sep. 30, 2014

16. On March 25, 2013, the Company made a $3,687 equity investment in TyraTech Inc. (“TyraTech”), a Delaware corporation that specializes in developing, marketing and selling pesticide products containing essential oils and other natural ingredients, to acquire an ownership position of approximately 29.27%. In February 2014, TyraTech issued 37,391,763 shares, raising approximately £1.87 ($3.1) million and issued 50,000,000 shares in July 2014 raising approximately £3.5 ($5.9) million. Due to the share issuance in both periods, the Company recognized a $954 gain from the dilution of the Company’s ownership position. Following the issuances of these new shares, as of September 30, 2014, the Company’s ownership position in TyraTech was approximately 19.28%. The Company utilizes the equity method of accounting with respect to this investment. As a result, our net income includes losses from equity method investments which represents our proportionate share of TyraTech’s estimated net losses for the current accounting period. For the nine months ended September 30, 2014, the Company recognized an operating loss of $633 ($237 for the three months ended September 30, 2014) as a result of the Company’s ownership position in TyraTech.

The Company’s investment in TyraTech is included in other assets on the condensed consolidated balance sheets. At September 30, 2014, the carrying value of the Company’s investment in TyraTech was $3,022, and the quoted market value of its shareholding was $6,321 based on the London Stock Exchange, Alternative Investment Market (“AIM”).

- Definition

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References+ Details